Home
Search
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

Exclusive interview with Sen. Todd Young
Good Day BIO Newsletter  •  September 27, 2024
This couldn't wait for Monday. We have an exclusive interview with Sen. Todd Young on biosecurity, plus good news about Centers for Medicare and Medicaid Services (CMS) rules governing drug rebates in Medicaid. (668 words, 3 minutes, 20 seconds)
Read More

Biotechnology is national security technology
Good Day BIO Newsletter  •  September 26, 2024
Today we have BIO’s new podcast episode on national security and more news you need to know. (824 words, 4 minutes, 7 seconds)
Read More

Pre-Clinical Safety (BioSafe) Committee Meeting
September 24, 2024
The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics.  For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).
Read More

Biotechnology is a National Security Asset
I am BIO Podcast  •  September 24, 2024
Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.
Read More
podcast

BIO Clinical Trial Diversity

PPRV reauthorization, IRA, and BIO's Governor of the Year
Good Day BIO Newsletter  •  September 23, 2024
A busy week in Washington brought progress on Pediatric Disease Priority Review Voucher (PPRV) reauthorization and conversations on price controls. Plus, BIO names Virginia Gov. Glenn Youngkin Governor of the Year. (790 words, 3 minutes, 57 seconds)
Read More

Virginia Governor Glenn Youngkin named BIO’s Governor of the Year
Press Release  •  September 17, 2024
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and commitment to strengthening biotechnology in their state. For over a decade, the award has recognized governors from across the country and both sides of the aisle.“Investing in biotechnology is investing in Virginia’s future,” said Governor Glenn Youngkin. “As the Commonwealth’s cutting-edge research triangle and network continues to expand, my administration is determined to remain at the forefront of fostering innovation. I am incredibly humbled to receive this award, and I look forward to further solidifying Virginia’s role as a leader in the life sciences industry.”“It is my honor to recognize Governor Youngkin with BIO’s 2024 Governor of the Year award for his leadership and support of the life sciences in Virginia,” said BIO President and CEO John F. Crowley. “From advancing innovative economic development initiatives for the bioscience ecosystem to investing in cutting-edge life science facilities across the state, Governor Youngkin has worked tirelessly on public policy solutions to help expand opportunities for researchers, entrepreneurs, and patients in Virginia.” "Virginia's $8 billion biotechnology industry is thriving because of the steadfast support of our governmental leaders and regional partnerships," said John Newby, CEO of the Virginia Biotechnology Association. "We thank Governor Youngkin and his administration for making transformational investments in our ecosystem, and for promoting pro-innovation policies that bring life-improving technologies to patients."###About BIOBIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from…
Read More

Privacy Policy
Thank you for visiting a member of the Biotechnology Innovation Organization (BIO) family of websites.  BIO and possibly affiliated organizations (“BIO” “we,” “our,” “us”) maintain these sites (each, strictly for reference in this privacy policy, a “BIO Site” and collectively “BIO Sites”). This privacy policy (the "Privacy Policy") applies to BIO Sites, mobile applications, and other online services that link to this Privacy Policy (the “Services”). By using the Services, you agree to the terms of this Privacy Policy.  In addition, by using the Services, you agree to the terms of the BIO TERMS OF USE, which govern your use of the Services.   Please note that the Privacy Policy does not apply to other websites of other companies, organizations or our members to which we may link, third party sites that link to us, or to our off-line activities.IF YOU DO NOT AGREE WITH ANY TERMS OR PRACTICES DESCRIBED IN THIS PRIVACY POLICY, OR BIO’S TERMS OF USE, THEN PLEASE DO NOT USE THE SERVICES.Information CollectionGenerally, you are not required to provide information about yourself when you visit the Services.  You can browse most of our BIO Sites and view our content anonymously (except regarding some information like Google analytics or “informatics”).  The type and amount of information BIO collects about you varies according to how you use the Services, BIO Sites or other BIO operations and events.  However, we may ask you for (or collect from you) some or all of the following types of information when you access various content or features, submit information to us, or directly contact us with questions or feedback:Contact information, such as name, e-mail address, phone number and postal address;Demographic information, such as gender, age, income, and residency status;Geolocation information and zip code information;Communication preferences and information about your interests;Search queries;Correspondence and other information that…
Read More

Poll shows strong bipartisan support for American biomanufacturing
Good Day BIO Newsletter  •  September 16, 2024
We’re packing a lot into one little newsletter: a new poll that shows strong bipartisan support for boosting American biomanufacturing, a House antitrust hearing on PBMs, and a lot more news you need to know to start your week. (762 words, 3 minutes, 48 seconds)
Read More

BIO files Amicus Brief in Colorado PDAB Case
Human Health  •  Amicus Brief  •  September 13, 2024
The Biotechnology Innovation Organization (“BIO”) respectfully moves the Court for leave to file an amicus brief in support of Plaintiffs’ response in opposition to the Defendants’ cross-motion for summary judgment. Copies of the proposed brief and proposed order are attached. Counsel for BIO has conferred with counsel for all parties: while counsel for Plaintiffs do not oppose this motion for leave to file an amicus brief, counsel for Defendants represented that Defendants oppose the motion.
Read More